SimazineGenital Neoplasms, FemaleVulvar NeoplasmsEndometrial NeoplasmsCarcinoma, EndometrioidEarly Detection of CancerOvarian NeoplasmsNeoplasmsPancreatic NeoplasmsBreast NeoplasmsNeoplasm InvasivenessLung NeoplasmsNeoplasm StagingProstatic NeoplasmsGene Expression Regulation, NeoplasticEndometrial HyperplasiaColonic NeoplasmsStomach NeoplasmsUterine NeoplasmsPrognosisNeoplasm MetastasisNeoplasm ProteinsTumor Markers, BiologicalCarcinomaRiskRisk FactorsCell Line, TumorGenetic Predisposition to DiseaseAdenocarcinomaMice, NudeHysterectomyTamoxifenSurvival RateSurvival AnalysisEndometriumRetrospective StudiesDNA, NeoplasmUterine Cervical NeoplasmsCystadenocarcinoma, SerousNeoplasms, Multiple PrimaryNeoplasm Recurrence, LocalNeoplasms, Second PrimaryColorectal NeoplasmsReceptors, EstrogenFollow-Up StudiesProspective StudiesOdds RatioEstrogensPostmenopauseReverse Transcriptase Polymerase Chain ReactionReceptors, ProgesteroneAntineoplastic AgentsCancer VaccinesRegistriesImmunohistochemistryAntineoplastic Agents, HormonalMutationRisk AssessmentColorectal Neoplasms, Hereditary NonpolyposisUrinary Bladder NeoplasmsDisease ProgressionSkin NeoplasmsUnited StatesRNA, MessengerAntineoplastic Combined Chemotherapy ProtocolsDrug Resistance, NeoplasmCarcinoma, Squamous CellCase-Control StudiesGene Expression ProfilingDNA MethylationAge FactorsDisease-Free SurvivalAdenocarcinoma, Clear CellXenograft Model Antitumor AssaysNeoplasm GradingGenotypeIncidenceNeoplasm TransplantationBlotting, WesternAntigens, NeoplasmLiver NeoplasmsCell Transformation, NeoplasticEstrogen Replacement TherapyCarcinoma, Non-Small-Cell LungCystadenocarcinoma, PapillaryProgestinsSensitivity and SpecificityCell ProliferationNeoplasms, Hormone-DependentSurvivorsNational Cancer Institute (U.S.)Thyroid NeoplasmsReceptor, erbB-2Germ-Line MutationRectal NeoplasmsKidney NeoplasmsRNA, Small InterferingAdenocarcinoma, MucinousChemotherapy, AdjuvantSEER Program